Guidance issued on joint sponsorship

Share this article:
Non-accredited providers must comply with the same firewall rules as their accredited counterparts to continue working with them as joint sponsors, according to new guidance.

Released on the Web site of the Accreditation Council for CME (ACCME), the guidance pertained to ACCME's new definition of a commercial interest as it relates to joint sponsors. Non-accredited providers have until Aug. 2009 to determine their status under the revised definition.

The ACCME said that, upon request, it would help a non-accredited entity determine if it is a commercial interest. Joint sponsors falling within the new definition can modify their corporate structures “so that the CME component of their organization will be an independent entity.”

Even before the guidance, some providers were already checking on the status of MECCs they work with by sending a letter to unaccredited providers to request they show organizational charts.

The status of joint sponsors had been cloudy since the ACCME's Aug. 24 policy update containing the redefinition of a commercial interest. That was followed by a set of FAQs issued Oct. 15 by ACCME stating that a commercial interest cannot be a joint sponsor.

Accredited providers have the same deadline to comply with the ACCME's new definition, as well as to ensure that all joint sponsors are in compliance.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.